2017
DOI: 10.1093/eurheartj/suw061
|View full text |Cite
|
Sign up to set email alerts
|

Hypertension and cardiovascular risk in young adult life: insights from CAVI

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
6
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
9
1

Relationship

2
8

Authors

Journals

citations
Cited by 10 publications
(6 citation statements)
references
References 39 publications
0
6
0
Order By: Relevance
“…This suggest poor attitude and practice of preventive measures among younger hypertensive patients. Their potential surprise and stigma due to relatively early diagnosis, belief in its reversibility, and perception of bleak future health status, may all contribute to inconsistencies in initial adoption of preventive measures 42 . Unfortunately, long-term inconsistencies in self-management may contribute to early onset of cardiovascular complications and high disease burden 42 .…”
Section: Discussionmentioning
confidence: 99%
“…This suggest poor attitude and practice of preventive measures among younger hypertensive patients. Their potential surprise and stigma due to relatively early diagnosis, belief in its reversibility, and perception of bleak future health status, may all contribute to inconsistencies in initial adoption of preventive measures 42 . Unfortunately, long-term inconsistencies in self-management may contribute to early onset of cardiovascular complications and high disease burden 42 .…”
Section: Discussionmentioning
confidence: 99%
“…15,16 While several studies have evaluated TI and its consequences in terms of glucose control in people with T2DM, [11][12][13] only a few studies have reported TI for blood pressure management in people with hypertension, 17,18 and there is lack of data on TI for blood pressure and lipid control simultaneously in incident T2DM. There is emerging global evidence on the cardiometabolic risk factor burden in people with hypertension 19 and dyslipidaemia, 20 and particularly on the increasing proportions of younger adults aged <50 years being less likely to be taking antihypertensive therapy (AHT), 19,21 resulting in significantly higher lifetime cardiovascular and mortality risk compared to older people with hypertension. 22 While a few studies have discussed the effect of hypertension 23 and dyslipidaemia 24,25 management as a cause of cardiovascular risk control failure, we are not aware of any population-level study that has evaluated the treatment patterns, delay in therapy initiation when needed, and associated medium-term impact on SBP and lipid control from the time of diagnosis of diabetes.…”
Section: Introductionmentioning
confidence: 99%
“…Traditional biomarkers used to risk stratify patients for treatment, such as left ventricular hypertrophy, tend to be less sensitive for identification of those at risk at younger ages, due to relatively shorter durations of exposure. 4,5 Left ventricular hypertrophy develops because blood pressure elevation increases afterload and left ventricular wall stress. However, gross changes in left ventricular morphology sufficient to reach criteria for the diagnosis of left ventricular hypertrophy are not often observed until severe disease is established.…”
Section: Introductionmentioning
confidence: 99%